Product Details:
| Minimum Order Quantity | 5 Bottle |
| Dose/Strength | 60 mg |
| Composition | Daclatasvir 60mg |
| Treatment | Chronic hepatitis C virus (HCV) infection |
| Manufacturer | Zydus Cadila |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
Product Details:
| Minimum Order Quantity | 10 Bottle |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Composition | Sofosbuvir 400 mg,Daclatasvir 60 mg |
| Manufactured By | Aprazer |
| Treatment | chronic hepatitis C |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
Sofokast plus (Daclatasvir 60mg + Sofosbuvir 400mg) is a combinational antiviral drug indicated for patients with chronic Hepatitis C viral (HCV) infection genotype 1 or 3. When used together, the fixed-dose combination (FDC) of daclatasvir and sofosbuvir shows characteristics like,
Both daclatasvir and sofosbuvir have a complex effect on the body. There are certain proteins (Table 1) that aids in multiplication (RNA replication and virion assembly) and the growth of viral cells. The FDC drug (daclatasvir + sofosbuvir) acts by blocking the activities of these special proteins thereby decreasing the viral toll.
Product Details:
| Minimum Order Quantity | 5 Bottle |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Composition | Sofosbuvir 400mg + Velpatasvir 100mg |
| Manufactured By | Aprazer Healthcare Pvt Ltd |
| Treatment | Treatment of Chronic hepatitis C virus (HCV) infection |
| Prescription/Non prescription | Prescription |
| Form | Tablet |